Andreas Kaufmann Andreas Kaufmann holds a degree in Biology from the University of Heidelberg (1992). Dr. Kaufmann completed his PhD at the German Cancer Centre working on tumour metastasis and EGF receptor signalling. In 1994, started working on Human Papillomavirus immunology and vaccine development at Loyola University at Chicago. In 1997, he proceeded to University Jena, Germany, and engaged in clinical testing of experimental vaccines and characterization of immune responses to HPV vaccination performing several clinical vaccination studies. The research group moved to Charité-Universitätsmedizin Berlin in 2005. Andreas Kaufmann is head of HPV research at the Department of Gynaecology. The main interests are i) characterization of tumour-specific immune responses and development and evaluation of tumour vaccination strategies ii) epidemiology of Human Papillomavirus (HPV) and cervical cancer and development and introduction of screening methods, iii) cancer stem cell biology and targeted treatment. HPV testing is performed for diagnostic purposes on patients and subjects recruited into studies. In addition the biologic and immunologic features of cancer stem cells of HPV-related cervical and head-and-neck cancer are investigated. Several cervical cancer screening implementation trials in LMIC were supported by the lab. The emphasis is on translational research making innovative methods and therapies available to patients.
